Antazoline in Comparison to Propafenone in Pharmacological Cardioversion of Atrial Fibrillation.

Summary

The purpose of this randomized, double blind, non-inferiority clinical trial was to compare the clinical efficacy and safety of antazoline with propafenone in the rapid conversion of paroxysmal non-valvular atrial fibrillation to sinus rhythm in patients without heart failure

Timeline

Start

2019-09-01

Primary completion

2025-09-01

Completion

2026-01-01

Drugs

Indications